Informações:
Falhas:
ID
34263
Descrição
Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies; ODM derived from: https://clinicaltrials.gov/show/NCT01251757
Link
https://clinicaltrials.gov/show/NCT01251757
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus NCT01251757
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
aged 40-80 years as of time of randomization.
boolean
ID.2
Item
two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.
boolean
ID.3
Item
flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)
boolean
ID.4
Item
continuous membership in kp for the 12 months prior to randomization.
boolean
ID.5
Item
willing to participate in the study.
boolean
ID.6
Item
evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin
boolean
ID.7
Item
use of warfarin or other antiplatelet agents for which aspirin use is contraindicated
boolean
ID.8
Item
end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated
boolean
ID.9
Item
use of medications for which use of statins is contraindicated
boolean